MTA1对胃癌细胞生物学行为的影响
该研究在胃癌BGC-823细胞中敲降或过表达MTA1,发现MTA1过表达增强细胞迁移、侵袭、增殖和裸鼠成瘤能力,敲降则相反;MTA1可能通过调控integrinβ1、cyclinD1和uPAR表达促进恶性表型。
要点
- MTA1过表达增强胃癌BGC-823细胞迁移、侵袭、增殖及体内成瘤能力
- 敲降MTA1可抑制胃癌细胞恶性表型
- MTA1可能通过上调integrinβ1、cyclinD1和uPAR发挥作用
核心结论
- MTA1促进人胃癌BGC-823细胞的侵袭、迁移和增殖,敲降MTA1则抑制成瘤并诱导良好表型。
- MTA1可能通过调控integrinβ1、cyclinD1和uPAR表达促进BGC-823细胞恶性表型。
研究设计与样本
- 利用pSilencer3.1-MTA1-siRNA和pcDNA3-MTA1质粒转染构建MTA1敲降和过表达的胃癌BGC-823细胞。
- 体外采用Boyden、划痕愈合、克隆形成和MTT实验检测生物学行为,体内通过裸鼠皮下注射检测成瘤能力。
- 采用RT-PCR和western blot检测integrinβ1、cyclinD1和uPAR表达。
主要发现
- 敲降MTA1组迁移和侵袭细胞数分别为25±2和12±1,低于对照组78±2和50±2及过表达组218±2和269±3(P<0.05)。
- 过表达MTA1组细胞生长加快、克隆形成能力增强,敲降组相反。
- RT-PCR显示敲降组cyclinD1、integrinβ1和uPAR mRNA下调,过表达组上调。
临床怎么用
- 该研究为胃癌MTA1的生物学功能提供临床前证据,提示MTA1可能作为潜在分子靶点。
- 尚需进一步临床研究验证MTA1在胃癌患者中的表达及靶向价值。
局限性
- 研究仅使用BGC-823单一细胞系和裸鼠模型,结论外推需谨慎。
- 未报告MTA1在临床胃癌样本中的表达及与预后关系。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To study the effects of metastasis associated 1 (MTA1) on biological characteristics such as migration, invasion and proliferation of gastric cancer (GC) cells. Methods: pSilencer3.1-MTA1-siRNA vector was used to establish human gastric cancer BGC-823 cell lines with constitutive MTA1-knockdown. Boyden, wound healing, clony forming assay and 3-(4, 5-dimethyl-2-thiazolyl)-2, 5-diphenyl-2H tetrazolium bromide (MTT) assay were performed to identify the effects of MTA1-deficiency on the biological behaviors of BGC-823 cells in vitro. Simultaneously, MTA1 overexpressed BGC-823 cell line was established by pcDNA3-MTA1 plasmid transfection for reverse verification. In addition, the role of MTA1 in the tumorigenicity of gastric cancer BGC823 cells in vivo was examined by subcutaneous injection of BGC-823 cells expressing different MTA1 levels into nude mice. Reverse transcription-polymerase chain reaction (RT-PCR) and western blot were used to detect the expression levels of integrin β1, cyclin D1 and uPAR in pSilencer3.1-MTA1-siRNA, pcDNA3-MTA1 transfected cells and control cells. Results: MTA1 knocked down or upregulated BGC-823 cell lines were successfully generated by transfecting pSilencer3.1-MTA1-siRNA or pcDNA3-MTA1 vector with lipofectamine 2000, respectively. The Boyden and wound healing experiments showed metastasis and invasion ability in MTA1 knocked down cells (25±2, 12±1) were significantly decreased when compared with those of control (78±2, 50±2) and MTA1-overexpressed groups (218±2, 269±3; P<0.05). The results of MTT assay and colony forming assay were significantly decreased when compared with those of showed that MTA1 overexpressed cells grew more rapidly and formed more colonies in vitro and induced worse malignant tumors in vivo, while MTA1 knocked down cells presented the reversed phenotype[control group (1 482.41±511.90) mm(3,) (1.39±0.29)g; MTA1 overexpressed group [(3 158.73±1 823.22) mm(3,) (2.23±0.51)g; MTA1-downregulated group (711.32±284.30)mm(3,) (0.87±0.21) g ; P<0.05)]. In addition, RT-PCR result showed that the expression level of MTA1 was positively correlated with the known metastasis-related genes (integrinβ1, cyclinD1, uPAR). Conclusions: MTA1 promotes the invasion, migration and proliferation of human gastric cancer BGC-823 cells. On the contrary, down-regulation of MTA1 significantly inhibits tumorigenicity of BGC-823 cells and induces favorable phenotypes. MTA1 may promote the malignant phenotype of BGC-23 cells via regulating the expressions of integrinβ1, cyclinD1 and uPAR. 目的: 研究肿瘤转移相关1(MTA1)基因对胃癌细胞迁移、侵袭、生长等多种生物学特性的影响。 方法: 利用pSilencer3.1-MTA1-siRNA载体构建稳定敲降MTA1的人胃癌BGC-823细胞,通过Boyden实验、划痕愈合实验、克隆形成实验和四甲基偶氮唑蓝(MTT)法检测敲降MTA1基因对BGC-823细胞多种生物学行为的影响。同时,利用pcDNA3-MTA1质粒过表达MTA1基因进行反向验证。在裸鼠皮下分别注射pSilencer3.1-MTA1-siRNA转染细胞、pcDNA3-MTA1转染细胞和对照细胞,检测MTA1基因对胃癌BGC823细胞体内成瘤能力的影响。采用逆转录聚合酶链反应(RT-PCR)测定pSilencer3.1-MTA1-siRNA转染组、pcDNA3-MTA1转染组和对照组细胞中integrinβ1、cyclinD1和尿激酶受体(uPAR)等转移相关基因的表达,观察其与MTA1表达的相关性。 结果: 成功构建了稳定敲降及过表达MTA1的BGC-823细胞。Boyden实验和划痕愈合实验结果显示,与对照组细胞比较,pSilencer3.1-MTA1-siRNA转染组发生迁移和侵袭的细胞数明显减少[分别为(25±2)和(12±1)个],pcDNA3-MTA1转染组发生迁移和侵袭的细胞数则明显增多[分别为(218±2)和(269±3)个],差异均有统计学意义(均P<0.01)。MTT法和克隆形成实验结果表明,pcDNA3-MTA1转染组细胞生长加快,克隆形成能力增强,pSilencer3.1-MTA1-siRNA转染组细胞与之相反。皮下成瘤实验显示,pSilencer3.1-MTA1-siRNA转染组肿瘤体积和重量分别为(711.32±284.30)mm(3)和(0.87±0.24)g,明显小于对照组[(1 482.41±511.90)mm(3)和(1.39±0.30)g],而pcDNA3-MTA1转染组肿瘤体积和肿瘤重量分别为(3 158.73±1 823.22)mm(3)和(2.23±0.51)g,明显大于对照组,差异均有统计学意义(均P<0.05)。RT-PCR检测结果显示,与对照组细胞比较,pSilencer3.1-MTA1-siRNA转染组细胞cyclinD1、integrinβ1和uPAR mRNA表达下调,而pcDNA3-MTA1转染组细胞cyclinD1、integrinβ1和uPAR mRNA表达上调。 结论: 敲降MTA1可削弱人胃癌BGC-823细胞的增殖、侵袭及迁移能力,而MTA1的过表达不仅能够增强BGC-823细胞的上述能力,还明显促进BGC-823细胞的体内成瘤能力,并诱发恶性胃癌表型。MTA1可能通过调控其他转移相关基因进而调控肿瘤细胞的多种生物学行为。.
引用
- Wang JS, Qian HL, Wang HJ, et al. [Effects of MTA1 on biological behaviors of gastric cancer cells]. Zhonghua Zhong Liu Za Zhi. 2018. PMID: 30139027. doi:10.3760/cma.j.issn.0253-3766.2018.08.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。